首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引34811
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jiaxian Yue,Jiaxiang Liu,Xiyu Kang et al. Jiaxian Yue et al.
Background: Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer is the most prevalent subtype among women but has a modest response to neoadjuvant chemotherapy (NAC). Acc...
Thomas Enzler,Sara Tweedy,Isabella Holmes et al. Thomas Enzler et al.
Pancreatic ductal adenocarcinoma (PDAC) is a difficult-to-treat cancer with a 5-year survival rate of only 13%. Intense chemotherapies are needed to control the disease. Surgical resection, if possible, is the only curative approach. Howeve...
Begoña Campos Balea,Martín Emilio Lázaro Quintela,Ma Carmen Areses Manrique et al. Begoña Campos Balea et al.
Background: Non-small cell lung cancer (NSCLC) with mutations in epidermal growth factor receptor exon 20 (EGFR Ex20Ins) is rare and resistant to conventional tyrosine kinase inhibitors (TKIs), limiting treatment options....
Haotian Wang,Jian Zeng,Zhengzhen Li et al. Haotian Wang et al.
Objective: To investigate blood-brain barrier (BBB) permeability abnormalities in cerebral white matter regions of non-brain metastatic lung cancer (LC) patients and their association with histopathological subtypes. ...
Yixuan Ma,Luyang Chang,Ruihua Mi et al. Yixuan Ma et al.
Background: Blinatumomab, a bispecific T-cell engager (BiTE), has significantly improved the efficacy of B-ALL treatment. However, its association with immune effector cell-associated neurotoxicity syndrome (ICANS) has ga...
Dianheng Bu,Arvind Sahu,Javier Torres Dianheng Bu
Introduction: Adjuvant endocrine therapy reduces cancer recurrence and improves overall survival in hormone receptor-positive breast cancer. Maintaining long-term adherence to endocrine therapy can be challenging, and non...
Zhenshui Wu,Kaining Ye,Jianming Weng et al. Zhenshui Wu et al.
Introduction: Neoadjuvant chemotherapy (NAC) is a cornerstone of breast cancer management, and accurate prediction of therapeutic efficacy is essential for optimizing treatment strategies and improving patient outcomes. ...
Jinci Mai,Huanhua Wu,Wanwan Wu et al. Jinci Mai et al.
Background: Obesity increases the risk of breast cancer, with dysfunctional metabolic activity in subcutaneous adipose tissue (SAT) implicated as a key underlying mechanism. This study sought to explore the correlation be...